Privacy Policy
Terms of Use
TM and ® are trademarks of Pfizer Inc., Pfizer Limited, or its affiliates and is used under license by Pfizer Canada ULC
© 2023 Pfizer Canada ULC. All rights reserved.
PP-NIV-CAN-0091-EN
You are about to enter the NIVESTYM Resource Hub!
Enter the Drug Identification Number (DIN) from your NIVESTYM package or prescription. The DIN can be found on the label of your medication (see image below).
The product information provided by this site is intended for patients, consumers, and caregivers in Canada.
You are about to enter the NYVEPRIA Resource Hub!
Enter the Drug Identification Number (DIN) from your NYVEPRIA package or prescription. The DIN can be found on the label of your medication (see image below).
The product information provided by this site is intended for patients, consumers, and caregivers in Canada.
You are about to enter the ZIRABEV Resource Hub!
Enter the Drug Identification Number (DIN) from your ZIRABEV package or prescription. The DIN can be found on the label of your medication (see image below).
The product information provided by this site is intended for patients, consumers, and caregivers in Canada.
You are about to enter the TRAZIMERA Resource Hub!
Enter the Drug Identification Number (DIN) from your TRAZIMERA package or prescription. The DIN can be found on the label of your medication (see image below).
The product information provided by this site is intended for patients, consumers, and caregivers in Canada.
You are about to enter the Ruxience Resource Hub!
Enter the Drug Identification Number (DIN) from your RUXIENCE package or prescription. The DIN can be found on the label of your medication (see image below).
The product information provided by this site is intended for patients, consumers, and caregivers in Canada.
You are about to enter the TRAZIMERA Resource Hub!
I have been prescribed TRAZIMERA for:
You are about to enter the
Ruxience Resource Hub!
You are about to enter the RUXIENCE Resource Hub!
I have been prescribed RUXIENCE for:
The product information provided by this site is intended for patients, consumers and caregivers in Canada.
You are entering a section of the site intended only for patients who have been prescribed TRAZIMERA for Breast Cancer.
You are entering a section of the site intended only for patients who have been prescribed TRAZIMERA for Gastric Cancer.
You are entering a section of the site intended only for patients who have been prescribed Ruxience for non-Hodgkin’s lymphoma or chronic lymphocytic leukemia.
You are entering a section of the site intended only for patients who have been prescribed Ruxience for rheumatoid arthritis, granulomatosis with polyangiitis, or microscopic polyangiitis.